Sagimet Biosciences Income Statement (2022-2026) | SGMT

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter) 18.19M10.46M30.39M30.67M30.67M31.35M32.20M32.20M32.46M32.35M32.56M
Revenue & cost
Revenue (Quarter) 2.00M
Operating items
Research & Development (Quarter) 6.37M6.84M5.85M4.49M4.68M4.96M5.66M5.26M6.31M12.65M14.22M15.34M7.25M9.73M6.73M7.00M
Wages, Salaries and Other (Quarter) 1.48M1.52M1.71M1.82M1.95M1.77M1.73M1.69M2.17M
Selling, General & Administrative (Quarter) 0.87M0.85M1.54M2.28M2.38M4.49M3.81M3.51M4.28M4.25M3.98M4.52M4.68M4.60M4.03M4.72M
Operating Expenses (Quarter) 7.24M7.69M7.39M6.76M7.06M9.45M9.47M8.77M10.59M16.90M18.20M19.86M11.93M14.33M10.77M11.71M
Operating Income (Quarter) -7.24M-7.69M-7.39M-6.76M-7.06M-7.45M-9.47M-8.77M-10.59M-16.90M-18.20M-19.86M-11.93M-14.33M-10.77M-11.71M
EBIT (Quarter) -7.24M-7.69M-7.39M-6.76M-7.06M-7.45M-9.47M-8.77M-10.59M-16.90M-18.20M-19.86M-11.93M-14.33M-10.77M-11.71M
Non-operating items
Interest & Investment Income (Quarter) -0.11M0.22M0.19M0.07M0.01M1.09M-1.43M-0.02M-0.03M0.46M1.99M-0.11M-0.04M1.43M1.20M-0.11M
Other Non Operating Income (Quarter) 0.14M0.22M0.19M0.18M0.27M1.10M1.31M2.14M2.47M2.28M1.99M1.69M1.54M1.43M1.20M1.06M
Net income details
EBT (Quarter) -7.34M-7.47M-11.19M-6.69M-28.36M-24.09M-66.01M-8.80M-10.67M-16.44M-82.59M-20.00M-22.74M-19.96M-13.37M-13.82M
Profit After Tax (Quarter) -7.10M-7.47M-7.20M-6.59M-6.79M-6.35M-8.15M-6.63M-8.12M-14.62M-16.20M-18.29M-10.39M-12.87M-9.56M-10.76M
Income from Continuing Operations (Quarter) -7.34M-7.47M-11.19M-6.69M-28.36M-24.09M-66.01M-8.80M-10.67M-16.44M-82.59M-20.00M-22.74M-19.96M-13.37M-13.82M
Consolidated Net Income (Quarter) -7.34M-7.47M-11.19M-6.69M-28.36M-24.09M-66.01M-8.80M-10.67M-16.44M-82.59M-20.00M-22.74M-19.96M-13.37M-13.82M
Income towards Parent Company (Quarter) -7.34M-7.47M-11.19M-6.69M-28.36M-24.09M-66.01M-8.80M-10.67M-16.44M-82.59M-20.00M-22.74M-19.96M-13.37M-13.82M
Net Income towards Common Stockholders (Quarter) -7.34M-7.47M-11.19M-6.69M-28.36M-24.09M-66.01M-8.80M-10.67M-16.44M-82.59M-20.00M-22.74M-19.96M-13.37M-13.82M
Additional items
EPS (Basic) (Quarter) -39.68-40.35-60.63-36.16-149.63-1.32-6.31-0.30-0.33-0.51-2.63-0.62-0.71-0.61-0.41-0.42
EPS (Diluted) (Quarter) -39.68-40.35-60.63-36.16-149.63-1.32-6.31-0.30-0.33-0.51-2.63-0.62-0.71-0.61-0.41-0.42
Shares Outstanding (Quarter) 0.19M0.19M0.18M0.19M0.19M18.19M10.46M29.04M31.91M32.14M31.35M32.20M32.20M32.46M32.35M32.56M
Shares Outstanding (Diluted) (Quarter) 0.19M0.19M0.18M0.19M0.19M18.19M10.46M29.04M31.91M32.14M31.35M32.20M32.20M32.46M32.35M32.56M
EBITDA (Quarter) -7.24M-7.69M-7.39M-6.76M-7.06M-7.45M-9.47M-8.77M-10.59M-16.90M-18.20M-19.86M-11.93M-14.33M-10.77M-11.71M
Interest Expenses (Quarter) 4.00M21.31M17.74M55.11M0.01M0.05M66.39M0.03M10.77M7.05M3.80M1.99M